Poloxamer synperonic F108 improves cellular transduction with lentiviral vectors

Journal of Gene Medicine

Volumn 14, Issue 8, 2012, Pages 549-560

  Höfig, Ines ^a,c   Atkinson, Michael J ^a,c   Mall, Sabine ^b,c   Krackhardt, Angela M ^b,c   Thirion, Christian ^a,c   Anastasov, Nataša ^a,c  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c SIRION BIOTECH GMBH   (Germany)

Author keywords

Cancer; Gene delivery; Gene transduction; Gene transfer; Lentiviruses; Lymphoma; Virology

Indexed keywords

HEXADIMETHRINE BROMIDE; LENTIVIRUS VECTOR; POLOXAMER; POLOXAMER SYNPERONIC F108; PROPIDIUM IODIDE; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; MEMBRANE STRUCTURE; PRIORITY JOURNAL; VIRAL GENE DELIVERY SYSTEM;

APOPTOSIS; CELL MEMBRANE; CELL PROLIFERATION; FLOW CYTOMETRY; GENES, REPORTER; GENETIC VECTORS; HEK293 CELLS; HUMANS; LENTIVIRUS; LEUKOCYTES, MONONUCLEAR; LUCIFERASES; PERMEABILITY; POLYAMINES; POLYETHYLENES; POLYPROPYLENES; SURFACE-ACTIVE AGENTS; TRANSDUCTION, GENETIC;

EID: 84865403679     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.2653     Document Type: Article

References (32)

1. Bukrinsky MI, Haggerty S, Dempsey MP, et al. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 1993; 365: 666-669.
2. Burns JC, Friedmann T, Driever W, Burrascano M, Yee JK. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci USA 1993; 90: 8033-8037.
3. Funke S, Maisner A, Muehlebach MD, et al. Targeted cell entry of lentiviral vectors. Mol Ther 2008; 16: 1427-1436.
4. Dull T, Zufferey R, Kelly M, et al. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998; 72: 8463-8471.
5. Gruber A, Kan-Mitchell J, Kuhen KL, Mukai T, Wong-Staal F. Dendritic cells transduced by multiply deleted HIV-1 vectors exhibit normal phenotypes and functions and elicit an HIV-specific cytotoxic T-lymphocyte response in vitro. Blood 2000; 96: 1327-1333.
6. Rouas R, Uch R, Cleuter Y, et al. Lentiviral-mediated gene delivery in human monocyte-derived dendritic cells: optimized design and procedures for highly efficient transduction compatible with clinical constraints. Cancer Gene Ther 2002; 9: 715-724.
7. Millington M, Aendt A, Boyd M, Applegate T, Shen S. Towards a clinically relevant lentiviral transduction protocol for primary human CD34 haematopoietic stem/progenitor cells. PLoS One 2009; 4: e6461.
8. Birmingham A, Anderson E, Sullivan K, et al. A protocol for designing siRNAs with high functionality and specificity. Nat Protoc 2007; 9: 2068-2078.
9. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-872.
10. Anastasov N, Klier M, Koch I, et al. Efficient shRNA delivery into B and T lymphoma cells using lentiviral vector-mediated transfer. J Hematop 2009; 2: 9-19.
11. Anastasov N, Bonzheim I, Rudelius M, et al. C/EBPbeta expression in ALK-positive anaplastic large cell lymphomas is required for cell proliferation and is induced by the STAT3 signaling pathway. Haematologica 2010; 95: 760-767.
12. Wurm M, Schambach A, Lindemann D, et al. The influence of semen-derived enhancer of virus infection on the efficiency of retroviral gene transfer. J Gene Med 2010; 12: 137-146.
13. Lin P, Correa D, Lin Y, Caplan AI. Polybrene inhibits human mesenchymal stem cell proliferation during lentiviral transduction. PLoS One 2011; 6: e23891.
14. Hesse J, Ebbesen P, Kristensen G. Correlation between polyion effect on cell susceptibility to in vitro infection with murine C-type viruses and polyion effect on some membrane-related functions. Intervirology 1978; 9: 173-183.
15. Castro BA, Weiss CD, Wiviott LD, Levy JA. Optimal conditions for recovery of the human immunodeficiency virus from peripheral blood mononuclear cells. J Clin Microbiol 1988; 26: 2371-2376.
16. Aubin RJ, Weinfeld M, Paterson MC. Factors influencing efficiency and reproducibility of polybrene-assisted gene transfer. Somat Cell Mol Genet 1988; 14: 155-167.
17. Lee RC, River LP, Pan FS, Ji L, Wollmann RL. Surfactant-induced sealing of electro-permeabilized skeletal muscle membranes in vivo. Proc Natl Acad Sci USA 1992; 89: 4524-4528.
18. Lu GW, Jun HW, Dzimianski MT, Qiu HC, McCall JW. Pharmacokinetic studies of methotrexate in plasma and synovial fluid following i.v. bolus and topical routes of administration in dogs. Pharm Res 1995; 12: 1474-1477.
19. Hannig J, Zhang D, Canaday DJ, et al. Surfactant sealing of membranes permeabilized by ionizing radiation. Radiat Res 2000; 154: 171-177.
20. Gebhart CL, Sriadibhatla S, Vinogradov S, Lemieux P, Alakhov V, Kabanov AV. Design and formulation of polyplexes based on pluronic-polyethyleneimine conjugates for gene transfer. Bioconjug Chem 2002; 13: 937-944.
21. Kabanov A, Zhu J, Alakhov V. Pluronic block copolymers for gene delivery. Adv Genet 2005; 53: 231-261.
22. Dishart KL, Denby L, George SJ, et al. Third-generation lentivirus vectors efficiently transduce and phenotypically modify vascular cells: implications for gene therapy. J Mol Cell Cardiol 2003; 35: 739-748.
23. Strappe PM, Hampton DW, Cachon-Gonzalez B, Fawcett JW, Lever A. Delivery of a lentiviral vector in a pluronic F127 gel to cells of the central nervous system. Eur J Pharm Biopharm 2005; 61: 126-133.
24. Platts KE, Lawry J, Hancock BW, Rees RC. Phenotypic and cell cycle analysis of human peripheral blood mononuclear cells activated with interleukin-2 and/or OKT3. Exp Cell Res 1993; 208: 154-160.
25. Rosenberg SA, Restifo NP, Yang JC, Morgan RA, Dudley ME. Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer 2008; 8: 299-308.
26. Scherr M, Battmer K, Bloemer U, Ganser A, Grez M. Quantitative determination of lentiviral vector particle numbers by real-time PCR. Biotechniques 2001; 31: 520-526.
27. Jones S, Peng PD, Yang S, et al. Lentiviral vector design for optimal T cell receptor gene expression in the transduction of peripheral blood lymphocytes and tumour-infiltrating lymphocytes. Hum Gene Ther 2009; 20: 630-640.
28. Hudecek M, Anderson LD, Nishida T, Riddell SR. Adoptive T-cell therapy for B-cell malignancies. Expert Rev Hematol 2009; 2: 517-532.
29. Batrakova EV, Li S, Vinogradov SV, Alakhov VY, Miller DW, Kabanov AV. Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidization. J Pharmacol Exp Ther 2001; 299: 483-493.
30. Krylova OO, Melik-Nubarov NS, Badun GA, Ksenofontov AL, Menger FM, Yaroslavov AA. Pluronic L61 accelerates flip-flop and transbilayer doxorubicin permeation. Chemistry 2003; 9: 3930-3936.
31. Stefaneanu L, Kovacs K. Effects of drugs on pituitary fine structure in laboratory animals. J Electron Microsc Tech 1991; 19: 80-89.
32. Pec EA, Wout ZG, Johnston TP. Biological activity of urease formulated in poloxamer 407 after intraperitoneal injection in the rat. J Pharm Sci 1992; 81: 626-630.